Navigation Links
Higher-risk kidneys may help solve organ shortage facing older adults
Date:11/13/2007

WINSTON-SALEM, N.C. New research from Wake Forest University Baptist Medical Center suggests that age alone shouldnt be a barrier to receiving a kidney transplant and that using donated kidneys that would once have been discarded may help alleviate the burgeoning organ shortage among older adults.

In the recent past, chronological age has been a considered a barrier for both organ donation and transplantation, said Phillip Moore, M.D., lead author. Our experience suggests that by transplanting organs that are considered higher-risk into carefully selected elderly patients, waiting times can be reduced and survival is similar, compared to standard-organ transplants.

The research, which involved 356 kidney transplants over a 59-month period, is reported in the journal Surgery.

Because of the aging population, there is an increasing need for kidney transplants among older adults. While the number of patients younger than 50 added to the waiting list for kidney transplants has remained constant during the last decade, the number of patients who are 65 or older has tripled. More than half of the people on the current active list are over age 50.

The crisis in organ supply challenges the transplant community to maximize the use of organs from all consenting donors, said Moore, a surgery resident.

In 2002, the United Network for Organ Sharing instituted a new policy to make better use of higher-risk organs that were once considered unsuitable for transplantation. These organs from expanded criteria donors (ECD) include kidneys from deceased donors over age 60 years or those over age 50 with health conditions such as high blood pressure, stroke or elevated levels of a protein called creatinine. Levels of creatinine, which is produced by muscle, are used to determine kidney function.

Controversy exists regarding the optimal approach to the elderly donor and recipient, said Moore. Ethical concerns have been ex
'/>"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Low Lead Exposures Can Hurt Kidneys
2. Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems
3. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
4. Tips for Parents: Teaching Children to Resolve Conflicts
5. Lipodissolve - Is it Safe???
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
8. Pill box organizers increase HIV patients adherence and improve viral suppression
9. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
China Cat-lovers Save Felines from Dinner Tables
...nts in the United Kingdom would have to consider a...to enjoy a pollution-free and greener future, a re...logy (CAT), has said. According to the report, t...ving vegetarian meals, running battery- operated c...
... French Prime Minister Michel Rocard, who underwen...ia, was discharged from hospital here on Tuesday....k his total memory and he is discharged from the h...mal as the health and memory is concerned," said G...
...stralian research has found that alcohol does not ...rding to Queensland Brain Institute director Profe...g destroys large sections of brain cell function s... strike, is erroneous. The research, presented to...
Other Medicine News:Health News:Radical Change in the Lifestyle Might Bring a Greener Future for Brits 2
(Date:9/4/2008)... real-time PCR testing for the diagnostic ... Sept. 4 /- The U.S. Food & Drug,Admi...aqMan(R) HBV Test,the first assay for quantitatin...est uses Roche,s real-time PCR technology to quant...nt,s blood. Doctors may use viral load,testing res...
(Date:9/4/2008)...r 4 /- Axentis Pharma AG has,initiate...and tolerability,of a new therapeutic formulation ... cystic fibrosis patients. The new formulation all...ed directly to the site of,infection. The forthcom...ferent doses of the new drug. Initial results are ...
(Date:9/3/2008)...inhua--,Pharmaceutical comp...nced,that it has enrolled the first subject into i...g Bronchitol in cystic fibrosis sufferers., The P...ross North,America, Argentina and Germany, and is ...roval to market Bronchitol for cystic fibrosis in ...
(Date:9/3/2008)...Vascular Disease Awareness Month, CHARLOTTESVILLE...ticals,LLC, a clinical-stage drug-development comp... unmet medical needs, announced today that it has ...trial of its lead drug,candidate trans sodium croc...n the clinicaltrials.gov Website, is investigating...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Molecular glue with new effect 10629 1Molecular glue with new effect 10629 2Webcast Alert 3A HCA Announces 4Q Year End 07 Earnings Report 10628 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 2Healthcare Technologies Ltd Announces the Change of its Name to 22NexGen Biofuels Ltd 22 2902 1
... 14, 2007 /PRNewswire-FirstCall/ -- Shire plc ,th...t/Hyperactivity,Disorder (ADHD), announced that it...tment portfolio at the American Psychiatric,Associ... in San,Diego. , "The upcoming clinical research t... to understanding the science of ADHD treatment,",...
...NESS WIRE)--May 15, 2007 - Gemin X Biotechnologies...he journal Blood,demonstrated that its lead compou...tro in Mantle Cell Lymphoma (MCL) cell lines and,p...-070) is a small,molecule specifically designed to... family, a validated cancer target, thus restoring...
Other Medicine Technology:Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 3Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 4Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 5Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 6Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 7Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...ries Freezing Stages fit easily onto most microtom...arts and need only the AC supply and a trickle of ...ediately and can be maintained indefinitely. Stag...g temperatures can be set for different kinds of t...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum
RIA kit for the quantitative determination of autoantibodies to insulin in serum
Medicine Products: